BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
Additions extend BioStem’s hospital channel to its BioRetain® wound care line PR Audio: POMPANO BEACH, Fla., September 4, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft […]
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
POMPANO BEACH, Fla., Sept. 03, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) –BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the H.C. Wainwright 28th Annual Global Investment […]
BioStem Technologies to Present at the Sidoti MicroCap Conference
POMPANO BEACH, Fla., August 14, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the Sidoti MicroCap Virtual […]
BioStem Technologies Reports Second Quarter 2026 Financial Results
Generates 29% sequential revenue growth, increasing to $7.9 million;Raises full-year 2026 revenue guidanceUplists to Nasdaq Capital Market PR Audio: POMPANO BEACH, FL, August 12, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (Nasdaq: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue […]
BioStem Technologies Announces Nasdaq Uplisting
Trading to Commence on August 7, 2026 POMPANO BEACH, Fla., August 6, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that The Nasdaq […]
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., July 29, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today […]
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
Advances progress towards planned Nasdaq uplisting PR Audio: POMPANO BEACH, Fla., July 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced the filing […]
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
POMPANO BEACH, Fla., June 10, 2026 — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the Planet MicroCap Las Vegas 2026 Conference. BioStem is scheduled to present on Wednesday, June 17, 2026, at […]
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
The new independent directors strengthen the Company’s board as seasoned executives bring deep expertise in life sciences commercialization, healthcare administration, and investment management PR Audio: POMPANO BEACH, Fla., June 9, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the […]
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
Strengthening balance sheet on path to Nasdaq uplisting POMPANO BEACH, Fla., May 22, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced it has entered into a securities […]